Gregory C. Fanning

China R&D
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Author Correction: Therapeutic strategies for hepatitis B virus infection: towards a cure.

Author Correction: Therapeutic strategies for hepatitis B virus infection: towards a cure.

Journal: Nature reviews. Drug discovery

Published: January 09, 2020

Noninvasive chimeric DNA profiling identifies tumor-originated HBV integrants contributing to viral antigen expression in liver cancer.

Noninvasive chimeric DNA profiling identifies tumor-originated HBV integrants contributing to viral antigen expression in liver cancer.

Journal: Hepatology international

Published: September 09, 2019

Therapeutic strategies for hepatitis B virus infection: towards a cure.

Therapeutic strategies for hepatitis B virus infection: towards a cure.

Journal: Nature reviews. Drug discovery

Published: July 09, 2019

A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer.

A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer.

Journal: Frontiers in oncology

Published: May 14, 2019

2,4-Diaminoquinazolines as Dual Toll-like Receptor (TLR) 7/8 Modulators for the Treatment of Hepatitis B Virus.

2,4-Diaminoquinazolines as Dual Toll-like Receptor (TLR) 7/8 Modulators for the Treatment of Hepatitis B Virus.

Journal: Journal of medicinal chemistry

Published: July 03, 2018

Design and synthesis of tetrahydropyridopyrimidine based Toll-Like Receptor (TLR) 7/8 dual agonists.

Design and synthesis of tetrahydropyridopyrimidine based Toll-Like Receptor (TLR) 7/8 dual agonists.

Journal: Bioorganic & medicinal chemistry letters

Published: March 09, 2018

Discovery of selective 2,4-diaminoquinazoline toll-like receptor 7 (TLR 7) agonists.

Discovery of selective 2,4-diaminoquinazoline toll-like receptor 7 (TLR 7) agonists.

Journal: Bioorganic & medicinal chemistry letters

Published: November 06, 2017

Identification and Optimization of Pyrrolo[3,2-d]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis B.

Identification and Optimization of Pyrrolo[3,2-d]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis B.

Journal: Journal of medicinal chemistry

Published: July 04, 2017

Novel Pyrimidine Toll-like Receptor 7 and 8 Dual Agonists to Treat Hepatitis B Virus.

Novel Pyrimidine Toll-like Receptor 7 and 8 Dual Agonists to Treat Hepatitis B Virus.

Journal: Journal of medicinal chemistry

Published: August 12, 2016

High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity.

High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: February 05, 2015

Plasma levels of growth-related oncogene (CXCL1-3) associated with fibrosis and platelet counts in HCV-infected patients.

Plasma levels of growth-related oncogene (CXCL1-3) associated with fibrosis and platelet counts in HCV-infected patients.

Journal: Alimentary pharmacology & therapeutics

Published: January 20, 2015

Nucleotide prodrugs of 2'-deoxy-2'-spirooxetane ribonucleosides as novel inhibitors of the HCV NS5B polymerase.

Nucleotide prodrugs of 2'-deoxy-2'-spirooxetane ribonucleosides as novel inhibitors of the HCV NS5B polymerase.

Journal: Journal of medicinal chemistry

Published: December 19, 2013

Showing 1-12 of 19

Last Updated: 09/26/2026